FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Emmanuelle Charafe-Jauffret

Research Profile

Disorders

Devices

Oligonucleotide Array Sequence Analysis

Procedures

Chemicals & Drugs

Anatomy

Physiology

Co-author Network

Publications

TOP 3
Emmanuelle Charafe-Jauffret; christophe ginestier
[Molecular entities of the breast cancer: the difference is in the origin].
christophe ginestier; Emmanuelle Charafe-Jauffret; Daniel Birnbaum
p53 and cancer stem cells: the mevalonate connexion.
christophe ginestier; Arnaud Guille; Emmanuelle Josselin; Gaelle Larderet; Florence Monville; Said Sebti; Patrice Viens; Julien Wicinski; François Bertucci; Daniel Birnbaum; Olivier Cabaud; Nathalie Cervera; Pascal Finetti; Emmanuelle Charafe-Jauffret
Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Emmanuelle Charafe-Jauffret (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Emmanuelle Charafe-Jauffret; christophe ginestier
[Molecular entities of the breast cancer: the difference is in the origin].
Annales de pathologie 2012;32(5 Suppl):S35-6.
2012: christophe ginestier; Emmanuelle Charafe-Jauffret; Daniel Birnbaum
p53 and cancer stem cells: the mevalonate connexion.
Cell cycle (Georgetown, Tex.) 2012;11(14):2583-4.
2012: christophe ginestier; Arnaud Guille; Emmanuelle Josselin; Gaelle Larderet; Florence Monville; Said Sebti; Patrice Viens; Julien Wicinski; François Bertucci; Daniel Birnbaum; Olivier Cabaud; Nathalie Cervera; Pascal Finetti; Emmanuelle Charafe-Jauffret
Mevalonate metabolism regulates Basal breast cancer stem cells and is a potential therapeutic target.
Stem cells (Dayton, Ohio) 2012;30(7):1327-37.
2012: christophe ginestier; Emmanuelle Charafe-Jauffret; Daniel Birnbaum
What drives breast cancer heterogeneity: oncogenic events or cell of origin?
The Journal of pathology 2012;227(3):267-9.
2012: Jean-Yves Pierga; Henri Roché; Thomas Bachelot; François-Clément Bidard; Mario Campone; Emmanuelle Charafe-Jauffret; Thierry Delozier; Jean-Marc Ferrero; Joseph GLIGOROV; Sandrine Kraemer; Florence Lerebours; Maria Pavlyuk; Thierry Petit; Patrice Viens
Neoadjuvant bevacizumab, trastuzumab, and chemotherapy for primary inflammatory HER2-positive breast cancer (BEVERLY-2): an open-label, single-arm phase 2 study.
The lancet oncology 2012;13(4):375-84.
2012: Suling Liu; Rachel Martin-Trevino; Sean McDermott; Sing J Ou; Shivani H Patel; Li Shang; Kevin J Zhang; Shoumin Bai; Daniel Birnbaum; Emmanuelle Charafe-Jauffret; Shawn G Clouthier; christophe ginestier; Gregory J Hannon; Amber Heath; Ingrid Ibarra; Jia Ke; Hasan Korkaya; Max S Wicha
MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells.
PLoS genetics 2012;8(6):e1002751.
2012: François Bertucci; Daniel Birnbaum; Emmanuelle Charafe-Jauffret; Anthony Ferrari; Pascal Finetti; Arnaud Lagarde; Gilles Thomas; Steven Van Laere; Patrice Viens; J Adelaide; Sylviane Olschwang
8q24 Cancer risk allele associated with major metastatic risk in inflammatory breast cancer.
PloS one 2012;7(5):e37943.
2012: Jocelyne Jacquemier; Daniel Olive; Marie-Laure Thibult; Benoît J Van den Eynde; François Bertucci; Daniel Birnbaum; Emmanuelle Charafe-Jauffret; Benjamin Esterni; Pascal Finetti; Gilles Houvenaeghel; Luc Xerri
High expression of indoleamine 2,3-dioxygenase in the tumour is associated with medullary features and favourable outcome in basal-like breast carcinoma.
International journal of cancer. Journal international du cancer 2012;130(1):96-104.
2011: christophe ginestier; Emmanuelle Charafe-Jauffret; Daniel Birnbaum
Breast tumor microenvironment: in the eye of the cytokine storm.
Cell cycle (Georgetown, Tex.) 2011;10(15):2420-1.
2011: christophe ginestier; Fabrice Sircoulomb; Emmanuelle Charafe-Jauffret; Max Chaffanet; Daniel Birnbaum
[ZNF703: a novel oncogene involved in breast cancer].
Médecine sciences : M/S 2011;27(4):357-9.
2011: Fabrice Sircoulomb; Nathalie Nicolas; Anthony Ferrari; Pascal Finetti; Ismahane Bekhouche; Estelle Rousselet; Aurélie Lonigro; José Adélaïde; Emilie Baudelet; Séverine Esteyriès; Julien Wicinski; Stéphane Audebert; Emmanuelle Charafe-Jauffret; Jocelyne Jacquemier; Marc Lopez; Jean-Paul Borg; Christos Sotiriou; Cornel Popovici; François Bertucci; Daniel Birnbaum; Max Chaffanet; christophe ginestier
ZNF703 gene amplification at 8p12 specifies luminal B breast cancer.
EMBO molecular medicine 2011;3(3):153-66.
2011: Jocelyne Jacquemier; Pierre Kerbrat; Anne-Laure Martin; Frédérique Penault-Llorca; Henri Roche; Daniel Serin; Patrice Viens; Daniel Birnbaum; Jean-Marie Boher; Mario Campone; Emmanuelle Charafe-Jauffret; Benjamin Esterni; Pascal Finetti; Fabrice Andre; François Bertucci
Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC-PACS 01 randomized trial.
Breast cancer research : BCR 2011;13(6):R109.
2011: Ismahane Bekhouche; Pascal Finetti; José Adelaïde; Anthony Ferrari; Carole Tarpin; Emmanuelle Charafe-Jauffret; Colette Charpin; Gilles Houvenaeghel; Jocelyne Jacquemier; Ghislain Bidaut; Daniel Birnbaum; Patrice Viens; Max Chaffanet; François Bertucci
High-resolution comparative genomic hybridization of inflammatory breast cancer and identification of candidate genes.
PloS one 2011;6(2):e16950.
2010: christophe ginestier; Suling Liu; Mark E Diebel; Hasan Korkaya; Ming Luo; Marty Brown; Julien Wicinski; Olivier Cabaud; Emmanuelle Charafe-Jauffret; Daniel Birnbaum; Jun-Lin Guan; gabriela dontu; Max S Wicha
CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts.
The Journal of clinical investigation 2010;120(2):485-97.
2010: Emmanuelle Charafe-Jauffret; christophe ginestier; Daniel Birnbaum
Cancer stem cells: just sign here!
Cell cycle (Georgetown, Tex.) 2010;9(2):229-30.
2010: Fabrice Sircoulomb; Ismahane Bekhouche; Pascal Finetti; José Adélaïde; Azza Ben Hamida; Julien Bonansea; Stéphane Raynaud; Charlène Innocenti; Emmanuelle Charafe-Jauffret; Carole Tarpin; Farhat Ben Ayed; Patrice Viens; Jocelyne Jacquemier; François Bertucci; Daniel Birnbaum; Max Chaffanet
Genome profiling of ERBB2-amplified breast cancers.
BMC cancer 2010;10():539.
2010: christophe ginestier; Emmanuelle Charafe-Jauffret; Daniel Birnbaum
Targeting breast cancer stem cells: fishing season open!
Breast cancer research : BCR 2010;12(5):312.
2010: Emmanuelle Charafe-Jauffret; christophe ginestier; Flora Iovino; Carole Tarpin; Mark Diebel; Benjamin Esterni; Gilles Houvenaeghel; Jean-Marc Extra; François Bertucci; Jocelyne Jacquemier; Luc Xerri; gabriela dontu; Giorgio Stassi; Yi Xiao; Sanford H Barsky; Daniel Birnbaum; Patrice Viens; Max S Wicha
Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(1):45-55.
2009: Anthony Gonçalves; Mathilde Deblock; Benjamin Esterni; Carole Tarpin; François Bertucci; Marine Gilabert; Emmanuelle Charafe-Jauffret; Jocelyne Jacquemier; Gilles Houvenaeghel; Jean-Marc Extra; Patrice Viens
Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status.
Anti-cancer drugs 2009;20(10):946-52.
2009: christophe ginestier; Julien Wicinski; Nathalie Cervera; Florence Monville; Pascal Finetti; François Bertucci; Max S Wicha; Daniel Birnbaum; Emmanuelle Charafe-Jauffret
Retinoid signaling regulates breast cancer stem cell differentiation.
Cell cycle (Georgetown, Tex.) 2009;8(20):3297-302.
2009: Hasan Korkaya; Amanda Paulson; Emmanuelle Charafe-Jauffret; christophe ginestier; Marty Brown; Julie Dutcher; Shawn G Clouthier; Max S Wicha
Regulation of mammary stem/progenitor cells by PTEN/Akt/beta-catenin signaling.
PLoS biology 2009;7(6):e1000121.
2009: François Bertucci; Pascal Finetti; Nathalie Cervera; Emmanuelle Charafe-Jauffret; Max Buttarelli; Jocelyne Jacquemier; Max Chaffanet; Dominique Maraninchi; Patrice Viens; Daniel Birnbaum
How different are luminal A and basal breast cancers?
International journal of cancer. Journal international du cancer 2009;124(6):1338-48.
2009: Emmanuelle Charafe-Jauffret; christophe ginestier; Flora Iovino; Julien Wicinski; Nathalie Cervera; Pascal Finetti; Min-Hee Hur; Mark E Diebel; Florence Monville; Julie Dutcher; Marty Brown; Patrice Viens; Luc Xerri; François Bertucci; Giorgio Stassi; gabriela dontu; Daniel Birnbaum; Max S Wicha
Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.
Cancer research 2009;69(4):1302-13.
2009: Emmanuelle Charafe-Jauffret; christophe ginestier; Daniel Birnbaum
Breast cancer stem cells: tools and models to rely on.
BMC cancer 2009;9():202.
2009: Jocelyne Jacquemier; Emmanuelle Charafe-Jauffret; Florence Monville; Benjamin Esterni; Jean-Marc Extra; Gilles Houvenaeghel; Luc Xerri; François Bertucci; Daniel Birnbaum
Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer.
Breast cancer research : BCR 2009;11(2):R23.
2008: Anthony Gonçalves; Emmanuelle Charafe-Jauffret; François Bertucci; Stéphane Audebert; Yves Toiron; Benjamin Esterni; Florence Monville; Carole Tarpin; Jocelyne Jacquemier; Gilles Houvenaeghel; Christian Chabannon; Jean-Marc Extra; Patrice Viens; Jean-Paul Borg; Daniel Birnbaum
Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes.
Molecular & cellular proteomics : MCP 2008;7(8):1420-33.
2008: Suling Liu; christophe ginestier; Emmanuelle Charafe-Jauffret; Hailey Foco; Celina G Kleer; Sofia D Merajver; gabriela dontu; Max S Wicha
BRCA1 regulates human mammary stem/progenitor cell fate.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(5):1680-5.
2008: Emmanuelle Charafe-Jauffret; Carole Tarpin; Patrice Viens; François Bertucci
Defining the molecular biology of inflammatory breast cancer.
Seminars in oncology 2008;35(1):41-50.
2008: Pascal Finetti; Nathalie Cervera; Emmanuelle Charafe-Jauffret; Christian Chabannon; Colette Charpin; Max Chaffanet; Jocelyne Jacquemier; Patrice Viens; Daniel Birnbaum; François Bertucci
Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis.
Cancer research 2008;68(3):767-76.
2008: Emmanuelle Charafe-Jauffret; Florence Monville; christophe ginestier; gabriela dontu; Daniel Birnbaum; Max S Wicha
Cancer stem cells in breast: current opinion and future challenges.
Pathobiology : journal of immunopathology, molecular and cellular biology 2008;75(2):75-84.
2008: Azza Ben Hamida; Inthidar Labidi; Karima Mrad; Emmanuelle Charafe-Jauffret; Saïda Ben Arab; Benjamin Esterni; Luc Xerri; Patrice Viens; François Bertucci; Daniel Birnbaum; Jocelyne Jacquemier
Markers of subtypes in inflammatory breast cancer studied by immunohistochemistry: prominent expression of P-cadherin.
BMC cancer 2008;8():28.
2007: José Adélaïde; Pascal Finetti; Ismahane Bekhouche; Laetitia Repellini; Jeannine Geneix; Fabrice Sircoulomb; Emmanuelle Charafe-Jauffret; Nathalie Cervera; Jérôme Desplans; Daniel Parzy; Eric Schoenmakers; Patrice Viens; Jocelyne Jacquemier; Daniel Birnbaum; François Bertucci; Max Chaffanet
Integrated profiling of basal and luminal breast cancers.
Cancer research 2007;67(24):11565-75.
2007: christophe ginestier; Hasan Korkaya; gabriela dontu; Daniel Birnbaum; Max S Wicha; Emmanuelle Charafe-Jauffret
[The cancer stem cell: the breast cancer driver].
Médecine sciences : M/S 2007;23(12):1133-9.
2007: christophe ginestier; Min Hee Hur; Emmanuelle Charafe-Jauffret; Florence Monville; Julie Dutcher; Marty Brown; Jocelyne Jacquemier; Patrice Viens; Celina G Kleer; Suling Liu; Anne F Schott; Daniel F Hayes; Daniel Birnbaum; Max S Wicha; gabriela dontu
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome.
Cell stem cell 2007;1(5):555-67.
2007: christophe ginestier; José Adélaïde; A Gonçalvès; L Repellini; Fabrice Sircoulomb; Anne Letessier; Pascal Finetti; Jeannine Geneix; Emmanuelle Charafe-Jauffret; François Bertucci; Jocelyne Jacquemier; Patrice Viens; Daniel Birnbaum
ERBB2 phosphorylation and trastuzumab sensitivity of breast cancer cell lines.
Oncogene 2007;26(50):7163-9.
2007: Emmanuelle Charafe-Jauffret; Florence Monville; François Bertucci; Benjamin Esterni; christophe ginestier; Pascal Finetti; Nathalie Cervera; Jeannine Geneix; Mohamed Hassanein; Laetitia Rabayrol; Hagay Sobol; Colette Taranger-Charpin; Luc Xerri; Patrice Viens; Daniel Birnbaum; Jocelyne Jacquemier
Moesin expression is a marker of basal breast carcinomas.
International journal of cancer. Journal international du cancer 2007;121(8):1779-85.
2007: Emmanuelle Charafe-Jauffret; Karima Mrad; Sana Intidhar Labidi; Azza Ben Hamida; Khaled Ben Romdhane; Mansour Ben Abdallah; christophe ginestier; Benjamin Esterni; Daniel Birnbaum; Farhat Ben Ayed; Luc Xerri; Patrice Viens; Amel Mezlini; Jocelyne Jacquemier
Inflammatory breast cancers in Tunisia and France show similar immunophenotypes.
Breast (Edinburgh, Scotland) 2007;16(4):352-8.
2007: Stéphane Garcia; Jean-Philippe Dales; Emmanuelle Charafe-Jauffret; Séverine Carpentier-Meunier; Lucile Andrac-Meyer; Jocelyne Jacquemier; Claudine Andonian; Marie-Noëlle Lavaut; Claude Allasia; Pascal Bonnier; Colette Charpin
Overexpression of c-Met and of the transducers PI3K, FAK and JAK in breast carcinomas correlates with shorter survival and neoangiogenesis.
International journal of oncology 2007;31(1):49-58.
2007: Emmanuelle Charafe-Jauffret; Max Chaffanet; François Bertucci; christophe ginestier; Jocelyne Jacquemier; Odile deLapeyrière; Daniel Birnbaum
[Towards an integrated cellular and molecular: definition of breast cancers].
Médecine sciences : M/S 2007;23(6-7):626-32.
2007: Stéphane Garcia; Jean-Philippe Dalès; Emmanuelle Charafe-Jauffret; Séverine Carpentier-Meunier; Lucile Andrac-Meyer; Jocelyne Jacquemier; Claudine Andonian; Marie-Noëlle Lavaut; Claude Allasia; Pascal Bonnier; Colette Charpin
Poor prognosis in breast carcinomas correlates with increased expression of targetable CD146 and c-Met and with proteomic basal-like phenotype.
Human pathology 2007;38(6):830-41.
2007: Stéphane Garcia; Jean-Philippe Dalès; Jocelyne Jacquemier; Emmanuelle Charafe-Jauffret; Daniel Birnbaum; Lucile Andrac-Meyer; Marie-Noëlle Lavaut; Claude Allasia; Séverine Carpentier-Meunier; Pascal Bonnier; Colette Charpin-Taranger
c-Met overexpression in inflammatory breast carcinomas: automated quantification on tissue microarrays.
British journal of cancer 2007;96(2):329-35.
2007: Anne Letessier; Sarah Garrido-Urbani; christophe ginestier; G Fournier; Benjamin Esterni; Florence Monville; José Adélaïde; Jeannine Geneix; Luc Xerri; Patrice Dubreuil; Patrice Viens; Emmanuelle Charafe-Jauffret; Jocelyne Jacquemier; Daniel Birnbaum; Marc Lopez; Max Chaffanet
Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer.
Oncogene 2007;26(2):298-307.
2007: Stéphanie Fabre-Lafay; Florence Monville; Sarah Garrido-Urbani; Carole Berruyer-Pouyet; christophe ginestier; Nicolas Reymond; Pascal Finetti; Richard Sauvan; José Adélaïde; Jeannine Geneix; Eric Lecocq; Cornel Popovici; Patrice Dubreuil; Patrice Viens; Anthony Gonçalves; Emmanuelle Charafe-Jauffret; Jocelyne Jacquemier; Daniel Birnbaum; Marc Lopez
Nectin-4 is a new histological and serological tumor associated marker for breast cancer.
BMC cancer 2007;7():73.
2006: christophe ginestier; Nathalie Cervera; Pascal Finetti; Séverine Esteyries; Benjamin Esterni; José Adélaïde; Luc Xerri; Patrice Viens; Jocelyne Jacquemier; Emmanuelle Charafe-Jauffret; Max Chaffanet; Daniel Birnbaum; François Bertucci
Prognosis and gene expression profiling of 20q13-amplified breast cancers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(15):4533-44.
2006: François Bertucci; Pascal Finetti; Nathalie Cervera; Emmanuelle Charafe-Jauffret; Emilie Mamessier; José Adélaïde; Stéphane Debono; Gilles Houvenaeghel; Dominique Maraninchi; Patrice Viens; Colette Charpin; Jocelyne Jacquemier; Daniel Birnbaum
Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers.
Cancer research 2006;66(9):4636-44.
2006: Emmanuelle Charafe-Jauffret; christophe ginestier; Florence Monville; Pascal Finetti; José Adélaïde; Nathalie Cervera; S Fekairi; Luc Xerri; Jocelyne Jacquemier; Daniel Birnbaum; François Bertucci
Gene expression profiling of breast cell lines identifies potential new basal markers.
Oncogene 2006;25(15):2273-84.
2006: Anne Letessier; Fabrice Sircoulomb; christophe ginestier; Nathalie Cervera; Florence Monville; Véronique Gelsi-Boyer; Benjamin Esterni; Jeannine Geneix; Pascal Finetti; Christophe Zemmour; Patrice Viens; Emmanuelle Charafe-Jauffret; Jocelyne Jacquemier; Daniel Birnbaum; Max Chaffanet
Frequency, prognostic impact, and subtype association of 8p12, 8q24, 11q13, 12p13, 17q12, and 20q13 amplifications in breast cancers.
BMC cancer 2006;6():245.
2005: Véronique Gelsi-Boyer; Béatrice Orsetti; Nathalie Cervera; Pascal Finetti; Fabrice Sircoulomb; Carole Rougé; Laurence Lasorsa; Anne Letessier; christophe ginestier; Florence Monville; Séverine Esteyriès; José Adélaïde; Benjamin Esterni; Catherine Henry; Stephen Ethier; Frédéric Bibeau; Marie-Joëlle Mozziconacci; Emmanuelle Charafe-Jauffret; Jocelyne Jacquemier; François Bertucci; Daniel Birnbaum; Charles Theillet; Max Chaffanet
Comprehensive profiling of 8p11-12 amplification in breast cancer.
Molecular cancer research : MCR 2005;3(12):655-67.
2005: Emmanuelle Charafe-Jauffret; christophe ginestier; Florence Monville; Samira Fekairi; Jocelyne Jacquemier; Daniel Birnbaum; François Bertucci
How to best classify breast cancer: conventional and novel classifications (review).
International journal of oncology 2005;27(5):1307-13.
2005: Jocelyne Jacquemier; Laetitia Padovani; Laetitia Rabayrol; Sunil R Lakhani; Frédérique Penault-Llorca; Yves Denoux; Maryse Fiche; Paulo Figueiro; Véronique Maisongrosse; Viviane Ledoussal; Jose Martinez Penuela; Nora Udvarhely; George El Makdissi; christophe ginestier; Jeannine Geneix; Emmanuelle Charafe-Jauffret; Luc Xerri; François Eisinger; Daniel Birnbaum; Hagay Sobol
Typical medullary breast carcinomas have a basal/myoepithelial phenotype.
The Journal of pathology 2005;207(3):260-8.
2005: Anne Letessier; christophe ginestier; Emmanuelle Charafe-Jauffret; Nathalie Cervera; José Adélaïde; Véronique Gelsi-Boyer; Jean-Charles Ahomadegbe; Jean Benard; Jocelyne Jacquemier; Daniel Birnbaum; Max Chaffanet
ETV6 gene rearrangements in invasive breast carcinoma.
Genes, chromosomes & cancer 2005;44(1):103-8.
2005: François Bertucci; Pascal Finetti; Jacques Rougemont; Emmanuelle Charafe-Jauffret; Nathalie Cervera; Carole Tarpin; Catherine Nguyen; Luc Xerri; Rémi Houlgatte; Jocelyne Jacquemier; Patrice Viens; Daniel Birnbaum
Gene expression profiling identifies molecular subtypes of inflammatory breast cancer.
Cancer research 2005;65(6):2170-8.
2005: Jocelyne Jacquemier; christophe ginestier; Jacques Rougemont; Valérie-Jeanne Bardou; Emmanuelle Charafe-Jauffret; Jeannine Geneix; José Adélaïde; Alane T Koki; Gilles Houvenaeghel; Jacques Hassoun; Dominique Maraninchi; Patrice Viens; Daniel Birnbaum; François Bertucci
Protein expression profiling identifies subclasses of breast cancer and predicts prognosis.
Cancer research 2005;65(3):767-79.
2004: François Bertucci; Pascal Finetti; Jacques Rougemont; Emmanuelle Charafe-Jauffret; Valéry Nasser; Béatrice Loriod; Jacques Camerlo; Rebecca Tagett; Carole Tarpin; Gilles Houvenaeghel; Catherine Nguyen; Dominique Maraninchi; Jocelyne Jacquemier; Rémi Houlgatte; Daniel Birnbaum; Patrice Viens
Gene expression profiling for molecular characterization of inflammatory breast cancer and prediction of response to chemotherapy.
Cancer research 2004;64(23):8558-65.
2004: Daniel Birnbaum; François Bertucci; christophe ginestier; Rebecca Tagett; Jocelyne Jacquemier; Emmanuelle Charafe-Jauffret
Basal and luminal breast cancers: basic or luminous? (review).
International journal of oncology 2004;25(2):249-58.
2004: François Bertucci; Carole Tarpin; Emmanuelle Charafe-Jauffret; Valérie-Jeanne Bardou; Anne-Chantal Braud; Agnès Tallet; Gwenaelle Gravis; Frédéric Viret; Anthony Gonçalves; Gilles Houvenaeghel; D Blaise; Jocelyne Jacquemier; Dominique Maraninchi; Patrice Viens
Multivariate analysis of survival in inflammatory breast cancer: impact of intensity of chemotherapy in multimodality treatment.
Bone marrow transplantation 2004;33(9):913-20.
2004: François Bertucci; Nathalie Borie; christophe ginestier; Agnès Groulet; Emmanuelle Charafe-Jauffret; José Adélaïde; Jeannine Geneix; Loïc Bachelart; Pascal Finetti; Alane T Koki; fabienne hermitte; Jacques Hassoun; Stéphane Debono; Patrice Viens; Vincent Fert; Jocelyne Jacquemier; Daniel Birnbaum
Identification and validation of an ERBB2 gene expression signature in breast cancers.
Oncogene 2004;23(14):2564-75.
2004: christophe ginestier; Emmanuelle Charafe-Jauffret; Frédérique Penault-Llorca; Jeannine Geneix; José Adélaïde; Max Chaffanet; Marie-Joëlle Mozziconacci; Jacques Hassoun; Patrice Viens; Daniel Birnbaum; Jocelyne Jacquemier
Comparative multi-methodological measurement of ERBB2 status in breast cancer.
The Journal of pathology 2004;202(3):286-98.
2004: Emmanuelle Charafe-Jauffret; Carole Tarpin; Valérie-Jeanne Bardou; François Bertucci; christophe ginestier; Anne-Chantal Braud; Brigitte Puig; Jeannine Geneix; Jacques Hassoun; Daniel Birnbaum; Jocelyne Jacquemier; Patrice Viens
Immunophenotypic analysis of inflammatory breast cancers: identification of an 'inflammatory signature'.
The Journal of pathology 2004;202(3):265-73.
2004: François Bertucci; Sébastien Salas; Séverine Eysteries; Valéry Nasser; Pascal Finetti; christophe ginestier; Emmanuelle Charafe-Jauffret; Béatrice Loriod; Loïc Bachelart; Jérôme Montfort; Geneviève Victorero; Frédéric Viret; Vincent Ollendorff; Vincent Fert; Marc Giovaninni; Jean-Robert Delpero; Catherine Nguyen; Patrice Viens; Geneviève Monges; Daniel Birnbaum; Rémi Houlgatte
Gene expression profiling of colon cancer by DNA microarrays and correlation with histoclinical parameters.
Oncogene 2004;23(7):1377-91.
2003: christophe ginestier; Valérie-Jeanne Bardou; Cornel Popovici; Emmanuelle Charafe-Jauffret; François Bertucci; Jeannine Geneix; José Adélaïde; Max Chaffanet; Jacques Hassoun; Patrice Viens; Jocelyne Jacquemier; Daniel Birnbaum
Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer.
International journal of cancer. Journal international du cancer 2003;107(5):854-62.
2003: Jocelyne Jacquemier; christophe ginestier; Emmanuelle Charafe-Jauffret; François Bertucci; Thierry Bege; Jeannine Geneix; Daniel Birnbaum
[Small but high throughput: how "tissue-microarrays" became a favorite tool for pathologists and scientists].
Annales de pathologie 2003;23(6):623-32.
2003: Emmanuelle Charafe-Jauffret; Carole Tarpin; christophe ginestier; François Bertucci; Frédérique Penault-Llorca; Luc Xerri; Daniel Birnbaum; Patrice Viens; Jacques Hassoun; Jocelyne Jacquemier
[Inflammatory breast carcinoma: towards molecular characterization?].
Annales de pathologie 2003;23(6):564-9.
2003: Daniel Birnbaum; José Adélaïde; Cornel Popovici; Emmanuelle Charafe-Jauffret; Marie-Joëlle Mozziconacci; Max Chaffanet
Chromosome arm 8p and cancer: a fragile hypothesis.
The lancet oncology 2003;4(10):639-42.
2003: Emmanuelle Charafe-Jauffret; François Bertucci; Olivier Ramuz; Elisabeth Devilard; Philippe Gaulard; Pierre Brousset; Rémi Houlgatte; Jacques Hassoun; Daniel Birnbaum; Luc Xerri
Characterization of Hodgkin's lymphoma-like undifferentiated carcinoma of the nasopharyngeal type as a particular UCNT subtype mimicking Hodgkin's lymphoma.
International journal of oncology 2003;23(1):97-103.
2003: Olivier Ramuz; Daniel Isnardon; Elisabeth Devilard; Emmanuelle Charafe-Jauffret; Jacques Hassoun; Françoise Birg; Luc Xerri
Constitutive nuclear localization and initial cytoplasmic apoptotic activation of endogenous caspase-3 evidenced by confocal microscopy.
International journal of experimental pathology 2003;84(2):75-81.
2002: Emmanuelle Charafe-Jauffret; Jean-François Moulin; christophe ginestier; Didier Bechlian; Nathalie Conte; Jeannine Geneix; José Adélaïde; Tetsuro Noguchi; Jacques Hassoun; Jocelyne Jacquemier; Daniel Birnbaum
Loss of heterozygosity at microsatellite markers from region p11-21 of chromosome 8 in microdissected breast tumor but not in peritumoral cells.
International journal of oncology 2002;21(5):989-96.
2002: Cornel Popovici; Céline Basset; François Bertucci; Béatrice Orsetti; José Adélaide; Marie-Joëlle Mozziconacci; Nathalie Conte; Anne Murati; christophe ginestier; Emmanuelle Charafe-Jauffret; Stephen Ethier; Marina Lafage-Pochitaloff; Charles Theillet; Daniel Birnbaum; Max Chaffanet
Reciprocal translocations in breast tumor cell lines: cloning of a t(3;20) that targets the FHIT gene.
Genes, chromosomes & cancer 2002;35(3):204-18.
2002: christophe ginestier; Emmanuelle Charafe-Jauffret; François Bertucci; François Eisinger; Jeannine Geneix; Didier Bechlian; Nathalie Conte; José Adélaïde; Yves Toiron; Catherine Nguyen; Patrice Viens; Marie-Joëlle Mozziconacci; Rémi Houlgatte; Daniel Birnbaum; Jocelyne Jacquemier
Distinct and complementary information provided by use of tissue and DNA microarrays in the study of breast tumor markers.
The American journal of pathology 2002;161(4):1223-33.
2002: Myriam Marcy; Bruno Chetaille; Emmanuelle Charafe-Jauffret; Marc Giovannini; Jean-Robert Delpéro; Geneviève Monges
[Signet ring cell carcinoma of the pancreas: a case report].
Annales de pathologie 2002;22(4):314-6.
2002: Nathalie Conte; Emmanuelle Charafe-Jauffret; Bénédicte Delaval; José Adélaïde; christophe ginestier; Jeannine Geneix; Daniel Isnardon; Jocelyne Jacquemier; Daniel Birnbaum
Carcinogenesis and translational controls: TACC1 is down-regulated in human cancers and associates with mRNA regulators.
Oncogene 2002;21(36):5619-30.
2001: Emmanuelle Charafe-Jauffret; Jocelyne Jacquemier; Bernard Lelong; P Meynard; MP Mathoulin-Portier; G Houvenhaegel; Jacques Hassoun
[Mammary carcinoma arising in microglandular adenosis: a case report].
Annales de pathologie 2001;21(5):435-8.
2001: F Ugolini; Emmanuelle Charafe-Jauffret; Valérie-Jeanne Bardou; Jeannine Geneix; José Adélaïde; F Labat-Moleur; Frédérique Penault-Llorca; M Longy; Jocelyne Jacquemier; Daniel Birnbaum; Marie-Josèphe Pébusque
WNT pathway and mammary carcinogenesis: loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type.
Oncogene 2001;20(41):5810-7.
2001: Emmanuelle Charafe-Jauffret; G Lehmann; francois fauchon; J F Michiels; Philippe Paquis; D Maraninchi; Jacques Hassoun
Vertebral metastases from pineoblastoma.
Archives of pathology & laboratory medicine 2001;125(7):939-43.
2000: Emmanuelle Charafe-Jauffret; V Moutardier; M Civatte; MC Charton-Bain; J R Delpero; Jacques Hassoun; Luc Xerri
[An ulcerative tumor of the fundic mucosa. What is your diagnosis? Diagnosis: Gastric plasma cell granuloma].
Annales de pathologie 2000;20(4):383-4.
2000: Jocelyne Jacquemier; MP Mathoulin-Portier; R Valtola; Emmanuelle Charafe-Jauffret; Jeannine Geneix; Gilles Houvenaeghel; Brigitte Puig; Valérie-Jeanne Bardou; Jacques Hassoun; Patrice Viens; Daniel Birnbaum
Prognosis of breast-carcinoma lymphagenesis evaluated by immunohistochemical investigation of vascular-endothelial-growth-factor receptor 3.
International journal of cancer. Journal international du cancer 2000;89(1):69-73.
1999: F Ugolini; José Adélaïde; Emmanuelle Charafe-Jauffret; C Nguyen; Jocelyne Jacquemier; B Jordan; Daniel Birnbaum; Marie-Josèphe Pébusque
Differential expression assay of chromosome arm 8p genes identifies Frizzled-related (FRP1/FRZB) and Fibroblast Growth Factor Receptor 1 (FGFR1) as candidate breast cancer genes.
Oncogene 1999;18(10):1903-10.